Each subject received the following treatments ( A and B ) with a 7-day washout period : treatment A consisted of gemigliptin 50 mg once daily administered orally for 6 days , followed by concomitant oral dosing of glimepiride 4 mg and gemigliptin 50 mg on day 7 ; treatment B consisted of a single dose of glimepiride 4 mg .